News - MabThera, Markets & Marketing


Popular Filters

Biocad enters deal for exporting rituximab biosimilar to Turkey


Biocad, one of Russia's leading biotechnology companies, has signed a definitive agreement on the export…

BiocadBiotechnologyEuropeGenericsKocak FarmaLicensingMabTheraMarkets & MarketingOncologyRituxanrituximabRoche

Stada Arz and Richter link up to develop and market two biosimilars: rituximab and trastuzumab


Germany’s Stada Arzneimittel (SAZ: GR) and Hungarian group Gedeon Richter (BDP: RICHTER) have signed…

BiotechnologyGedeon RichterGenericsHerceptinLicensingMabTheraMarkets & MarketingOncologyRituxanrituximabRocheSTADA Arzneimitteltrastuzumab

Back to top